Affinage · Plasmodium

MAT1

PF3D7_0512300 · CDK-activating kinase assembly factor MAT1

Annotated
2026-09-07
8 papers in source corpus 3 papers cited in narrative 5 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

MAT1 (PF3D7_0512300) is a nuclear effector subunit of a trimeric CDK-activating kinase-like complex in Plasmodium falciparum, assembling with the CDK7 homolog Pfmrk and the cyclin H homolog PfCyc1 (PMID:16737745, PMID:28611247). Its C-terminal domain physically engages Pfmrk and functions as the kinase-activator domain, stimulating Pfmrk activity in a cyclin-dependent manner (PMID:16737745, PMID:20332005). Functionally, MAT1 both promotes RNA polymerase II CTD phosphorylation and redirects Pfmrk substrate specificity, enabling phosphorylation of the DNA replication proteins PfRFC-5 and PfMCM6, thereby linking the complex to transcriptional regulation and DNA replication (PMID:16737745, PMID:20332005). Notably, MAT1-activated Pfmrk phosphorylates the CTD but not PfPK5, indicating the complex acts as a CTD kinase rather than a canonical CAK in this context (PMID:16737745). MAT1 and Pfmrk co-localize to the parasite nucleus (PMID:20332005). Beyond its role within this complex, no genetic loss-of-function phenotype or structural characterization of MAT1 itself has been reported in the available corpus.

Mechanistic history

Synthesis pass · year-by-year structured walk · 4 steps
  1. 2006 High

    Establishing whether Pfmrk required an accessory activator resolved how this Plasmodium CDK7 homolog is switched on; MAT1 was shown to be the effector that stimulates Pfmrk kinase activity toward the RNA Pol II CTD.

    Evidence In vitro kinase assays with recombinant proteins testing RNA Pol II CTD and PfPK5 as substrates

    PMID:16737745

    Open questions at the time
    • Did not map the region of MAT1 responsible for activation
    • Physiological substrates in the parasite not defined
    • No structural basis for activation
  2. 2010 Medium

    Defining the physical basis of activation and the subcellular context showed that MAT1 directly binds Pfmrk through its C-terminal domain and that the two proteins co-localize in the nucleus, consistent with an in vivo assembly.

    Evidence Reciprocal co-immunoprecipitation with domain mapping and immunofluorescence of GFP/RFP-tagged proteins

    PMID:20332005

    Open questions at the time
    • Single-lab interaction data without structural detail
    • Timing of complex assembly across the cell cycle unknown
  3. 2010 Medium

    Determining whether MAT1 does more than activate kinase output revealed that it confers substrate specificity, directing Pfmrk to phosphorylate the DNA replication factors PfRFC-5 and PfMCM6.

    Evidence Bacterial two-hybrid screen of a P. falciparum cDNA library and in vitro phosphorylation assays

    PMID:20332005

    Open questions at the time
    • In vitro phosphorylation not validated as an in vivo regulatory event
    • Functional consequence for replication timing not tested
  4. 2017 Medium

    Confirming the native complex composition, pulldown of the cyclin subunit demonstrated that MAT1, Pfmrk, and PfCyc1 form a trimeric complex in the parasite rather than only in reconstituted systems.

    Evidence Co-immunoprecipitation of PfCyc1 from parasite lysate with mass spectrometry/western detection

    PMID:28611247

    Open questions at the time
    • Stoichiometry and structure of the trimeric complex not resolved
    • Regulation of complex formation across the life cycle unknown

Open questions

Synthesis pass · forward-looking unresolved questions
  • The essentiality and in vivo function of MAT1 itself — through genetic disruption and separation of its transcriptional versus replication-linked roles — remain unresolved.
  • No loss-of-function/knockout phenotype for MAT1 reported
  • No structure of MAT1 or the trimeric complex
  • In vivo relevance of PfRFC-5/PfMCM6 phosphorylation not established

Mechanism profile

Synthesis pass · controlled-vocabulary classification
Complex memberships
PfCyc1/PfMAT1/PfMRK (Pfmrk) trimeric CDK-activating kinase-like complex

Evidence

Reading pass · 5 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2006 PfMAT1 (PF3D7_0512300) was identified as an effector protein that stimulates Pfmrk kinase activity in a cyclin-dependent manner; addition of PfMAT1 stimulated RNA polymerase II CTD phosphorylation but had no effect on the inability of Pfmrk to phosphorylate PfPK5, suggesting Pfmrk functions as a CTD kinase rather than a CAK in this context. In vitro kinase assay with recombinant proteins; substrate phosphorylation assays (RNA Pol II CTD, PfPK5) Molecular and biochemical parasitology High 16737745
2010 Co-immunoprecipitation demonstrated physical interaction between PfMAT1 (PF3D7_0512300) and Pfmrk, and mapped the C-terminal domain of PfMAT1 as the Pfmrk activator domain. Co-immunoprecipitation; domain-mapping experiments Molecular and biochemical parasitology Medium 20332005
2010 Immunofluorescence using GFP- and RFP-tagged versions of Pfmrk and PfMAT1 (PF3D7_0512300), respectively, demonstrated co-localization of the two proteins to the parasite nucleus. Immunofluorescence microscopy with GFP/RFP-tagged proteins Molecular and biochemical parasitology Medium 20332005
2010 PfMAT1 (PF3D7_0512300) confers substrate specificity to the Pfmrk kinase complex; in the presence of PfMAT1, Pfmrk phosphorylates DNA replication proteins PfRFC-5 and PfMCM6 (identified as Pfmrk interactors via bacterial two-hybrid screen). Bacterial two-hybrid screen of P. falciparum cDNA library; in vitro kinase phosphorylation assays Molecular and biochemical parasitology Medium 20332005
2017 Co-immunoprecipitation of PfCyc1 from P. falciparum parasites identified PfMAT1 (PF3D7_0512300) and PfMRK as specific interaction partners, establishing a conserved PfCyc1/PfMAT1/PfMRK trimeric complex in the parasite. Co-immunoprecipitation from parasite lysate followed by mass spectrometry/western blot mBio Medium 28611247

Source papers

Stage 0 corpus · 8 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Identification of an effector protein and gain-of-function mutants that activate Pfmrk, a malarial cyclin-dependent protein kinase. Molecular and biochemical parasitology 29 16737745
2017 The Malaria Parasite Cyclin H Homolog PfCyc1 Is Required for Efficient Cytokinesis in Blood-Stage Plasmodium falciparum. mBio 28 28611247
2010 The malarial CDK Pfmrk and its effector PfMAT1 phosphorylate DNA replication proteins and co-localize in the nucleus. Molecular and biochemical parasitology 25 20332005
2016 Regulation of DNA replication proteins in parasitic protozoans: possible role of CDK-like kinases. Current genetics 9 26780367
2009 Evolutionary divergence of Plasmodium falciparum: sequences, protein-protein interactions, pathways and processes. Infectious disorders drug targets 8 19519480
2007 In silico three-dimensional pharmacophores for aiding the discovery of the Pfmrk (Plasmodium cyclin-dependent protein kinases) specific inhibitors for the therapeutic treatment of malaria. Expert opinion on drug discovery 3 23484876
2003 Can mosquitoes be bitten? A new hope for anti-malarial drug design. Structure (London, England : 1993) 2 14604516
2013 In silico characterization and molecular dynamics simulation of Pfcyc-1, a cyclin homolog of Plasmodium falciparum. Journal of biomolecular structure & dynamics 0 23998890